Published February 21, 1984
| Version v1
Patent
Radioimmunoassay for cyclic nucleotides
Creators
Description
An improved radioimmunoassay for the determination of cyclic nucleotides in body fluids which comprises adding a source of divalent cation prior to assay minimizes the effects of both endogenous calcium ion and EDTA used as an anticoagulant in blood plasma samples
Availability note (English)
U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.Additional details
Publishing Information
- Imprint Pagination
- v p.
- IPC:
- Int. Cl. G01N 33/56; G01N 33/58; G01N 33/60.
- IPC
- Int. Cl. G01N 33/56; G01N 33/58; G01N 33/60.
- Patent number
- US patent document 4,433,061/A/
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 16014184
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- ADDITIVES; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD PLASMA; BODY FLUIDS; CALCIUM IONS; CATIONS; CHEMICAL COMPOSITION; EDTA; NUCLEOTIDES; RADIOIMMUNOASSAY
- Descriptors DEC
- AMINO ACIDS; ATOMIC IONS; BIOLOGICAL MATERIALS; BLOOD; CARBOXYLIC ACIDS; CHARGED PARTICLES; CHELATING AGENTS; DRUGS; HEMATOLOGIC AGENTS; IONS; ISOTOPE APPLICATIONS; MATERIALS; ORGANIC ACIDS; ORGANIC COMPOUNDS; TRACER TECHNIQUES
Optional Information
- Notes
- PAT-APPL-269155.